References
- Pedersen C, Schneider PJ, Scheckelhoff D. ASHP National survey of pharmacy practice in hospital settings: dispensing and administration-2002. Am J Health System Pharm 2003;60:52–68.
- American Society of Hospital Pharmacists. ASHP Guidelines for oral solids and liquids in single unit and unit dose packages. Am J Hosp Pharm 1983;40:451–452.
- Drug Packaging Materials. In: Jenkins W, Osborn K, editors. Packaging drugs and pharmaceuticals. Informa Health Care.: CRC Press, Boca Raton, FL; 1993. p 99–142.
- Janes J. Results of survey–unit-dose repackaging. Hospital Pharm 1983;18:519–522.
- Blister strip and sachet packaging. In: Dean D, Evans R, Hall I, editors. Pharmaceutical packaging technology. London: Taylor & Francis; 2000. p 517–539.
- Allen D. Forming barrier materials for blister packages. Pharm Med Packag News 1999;7:45–53.
- Allinson J, Dansereau R, Sakr A. The effects of packaging on the stability of a moisture sensitive compound. Int J of Pharmaceut 2001;221:49–56.
- World Health Organization. Repackaging and re-labeling. In: Good trade and distribution practices for pharmaceutical starting materials. WHO Technical Report Series No. 917, 2003;Annex 2:49–50.
- ICH Guidance for Industry. “Q1B Photostability Testing of New Drug Substances and Products” November 2003.
- USP-NF Online. <671> Containers-Permeation. United States Pharmacopoeia 28/National Formulary 23, 2005. Accessed January 2005. www.usp.org.
- USP-NF Online. <1146> Packaging Practice-Repackaging A Single Solid Oral Drug Product into A Unit Dose Container. United States Pharmacopoeia 28/National Formulary 23, 2005. Accessed January 2005. www.usp.org.
- Boles L, Schoenwald P, Schoenwald R. Furosemide a pharmacokinetic/pharmacodynamic review. Clin Pharm 1990;18:381–408.
- Moore D, Sithipitaks V. Photolytic degradation of frusemide. J Pharm Pharmacol 1983;35:489–493.
- Rwobotham P, Stanford J, Sugden J. Some aspects of the photochemical degradation of frusemide. Pharm Acta Helv 1976;51:304–307.
- Ballereau F, Prazuck T, Schrive I, lafleuriel M, Rozec D, Fisch A, Lafaix C. Stability of essential drugs in the field: results of a study conducted over a two-year period in Burkina Faso. Am J Trop Med Hyg 1997;57:31–36.
- Akbuga J, Gursoy A. The effect of moisture sorption and desorption on furosemide tablet properties. Drug Dev Ind Pharm 1987;13:1827–1845.
- Shah R, Prasanna H, Rothman B, Khan M. Stability of ranitidine syrup repackaged in unit dose containers. Am J Health System Pharm 2008;65:325–329.
- Gupta A, Ciavarella AB, Rothman B, Faustino PJ, Khan MA. Stability of Gabapentin capsules in repackaged unit-dose containers. Am J Health System Pharm 2009;66:1376–1380.
- Yang Y, Gupta A, Carlin A, Faustino P, Lyon R, Ellison C, Rothman B, Khan M. Comparative stability of repackaged metoprolol tartrate tablets. Int J of Pharm 2010;385:92–97.
- Bowen L, Mangan M, Haywood A, Glass B. Stability of furosemide tablets repackaged in dose administration aids. J Pharm Pract Res 2007;37:178–181.
- AL-Obaid M, Al-Shammary F, Al-Rashood K, Mian M. Analytical profiles of furosemide. Anal Profiles Drug Substance Excipients 1989;18:153–193.
- Asker F, Ferdous A. Photodegradation of furosemide solutions. PDA J of Pharm Sci Tech 1996;50:158–162.